UA52334U - Фармацевтическая композиция на основе парацетамола и диклофенака натрия - Google Patents
Фармацевтическая композиция на основе парацетамола и диклофенака натрияInfo
- Publication number
- UA52334U UA52334U UAU201001479U UAU201001479U UA52334U UA 52334 U UA52334 U UA 52334U UA U201001479 U UAU201001479 U UA U201001479U UA U201001479 U UAU201001479 U UA U201001479U UA 52334 U UA52334 U UA 52334U
- Authority
- UA
- Ukraine
- Prior art keywords
- paracetamol
- pharmaceutical composition
- composition based
- sodium diclofenac
- sodium
- Prior art date
Links
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 title abstract 3
- KPHWPUGNDIVLNH-UHFFFAOYSA-M diclofenac sodium Chemical compound [Na+].[O-]C(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl KPHWPUGNDIVLNH-UHFFFAOYSA-M 0.000 title abstract 3
- 229960005489 paracetamol Drugs 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- CBOJBBMQJBVCMW-BTVCFUMJSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;hydrochloride Chemical compound Cl.O=C[C@H](N)[C@@H](O)[C@H](O)[C@H](O)CO CBOJBBMQJBVCMW-BTVCFUMJSA-N 0.000 abstract 2
- 229960001911 glucosamine hydrochloride Drugs 0.000 abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 229910002012 Aerosil® Inorganic materials 0.000 abstract 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 abstract 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- 229930006000 Sucrose Natural products 0.000 abstract 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 235000013681 dietary sucrose Nutrition 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract 1
- 239000008108 microcrystalline cellulose Substances 0.000 abstract 1
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract 1
- -1 or tabletose Substances 0.000 abstract 1
- 229940083542 sodium Drugs 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000007909 solid dosage form Substances 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 229960004793 sucrose Drugs 0.000 abstract 1
- 239000000454 talc Substances 0.000 abstract 1
- 229910052623 talc Inorganic materials 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Фармацевтическая композиция на основе парацетамола и диклофенака натрия, предназначенная для перорального приема в твердой дозированной форме, содержит глюкозамина гидрохлорид и вспомогательные фармацевтически приемлемые вещества лактозу или сахарозу, или таблетозу, микрокристаллическую целлюлозу, аэросил или силикс, крахмал или натрия кроскармеллозу, или колидон, кальция стеарат или магния стеарат, тальк. При этом фармацевтическая комбинация содержит терапевтически эффективное количество глюкозамина гидрохлорида, парацетамола и диклофенака натрия.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201001479U UA52334U (ru) | 2010-02-12 | 2010-02-12 | Фармацевтическая композиция на основе парацетамола и диклофенака натрия |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201001479U UA52334U (ru) | 2010-02-12 | 2010-02-12 | Фармацевтическая композиция на основе парацетамола и диклофенака натрия |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA52334U true UA52334U (ru) | 2010-08-25 |
Family
ID=52011739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201001479U UA52334U (ru) | 2010-02-12 | 2010-02-12 | Фармацевтическая композиция на основе парацетамола и диклофенака натрия |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA52334U (ru) |
-
2010
- 2010-02-12 UA UAU201001479U patent/UA52334U/ru unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL199472A0 (en) | Non-effervescent, orally disintegrating solid pharmaceutical dosage forms, processes for the preparation of the same and uses thereof | |
| NZ599847A (en) | Pharmaceutical composition comprising a glp-1 agonist and methionine | |
| MX2010004323A (es) | Formas de dosificacion oral que comprenden acetato de licarbazepina. | |
| MY153730A (en) | Dual-acting pharmaceutical compositions based on superstructures of angiotensin receptor antagonist/blocker (arb) and neutral endopeptidase (nep) inhibitor | |
| GB2448224B (en) | Solid orally administered pharmaceutical composition for the reduction of side-effects of a dopaminergic agent | |
| MX343358B (es) | Tabletas de acetato de ulipristal. | |
| GEP20125624B (en) | Pyridazine derivatives as smo inhibitors | |
| MX2009003372A (es) | Formas de dosificacion de pelicula no mucoadhesiva. | |
| CO6440564A2 (es) | Composiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona | |
| MA31706B1 (fr) | Formulations galéniques de composés organiques | |
| MX2010007083A (es) | Combinacion anti-retroviral. | |
| PL2205279T3 (pl) | Farmaceutyczna kombinacja aliskirenu i walsartanu | |
| EP3276004A3 (en) | Methods for treating chronic kidney disease | |
| NZ593199A (en) | Milnacipran for the long-term treatment of fybromyalgia syndrome | |
| WO2010012459A3 (en) | A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms | |
| TNSN08385A1 (en) | Delayed-release glucocorticoid treatment of rheumatoid disease | |
| GB0703674D0 (en) | A Process For The Preparation of an Orally Administered Unit Dose Tablet | |
| WO2010079433A3 (en) | Pharmaceutical composition comprising melogliptin | |
| WO2014141295A3 (en) | Treatment and prophylaxis of kidney diseases | |
| MY153610A (en) | Fixed dose combination in form of a bilayered or monolayered tablet of aliskiren and amlodipine | |
| UA52334U (ru) | Фармацевтическая композиция на основе парацетамола и диклофенака натрия | |
| UA52336U (ru) | Фармацевтическая композиция на основе глюкозамина гидрохлорида с хондропротекторным и анальгетическим действием | |
| MX2011009844A (es) | Composicion farmaceutica que comprende alisquireno. | |
| MY143949A (en) | An orally active thrombin inhibitor | |
| MX2011009846A (es) | Formulaciones galenicas de una combinacion de dosis fija de valsartan y alisquireno. |